On the recordNovember 6, 2017
Does anyone see anything wrong with Allergan trying to get additional patents on this drug, making those applications, and initially being granted them?
Source
congress.govDoes anyone see anything wrong with Allergan trying to get additional patents on this drug, making those applications, and initially being granted them?
Issa questions the legitimacy of Allergan's patent applications.
Share
More from Darrell Issa
South Korea is an American ally and an economic success story, which is why its recent and continuing actions restricting American companies — like its 20-year ban on Google Maps — are so troubling.
Yesterday we also introduced to the House of Representatives the Sanctuary City Accountability Act.
I can hold this seat. I’m not quitting on California and neither should anyone else.
I suspect that the gentleman is prepared to close as am I, and I reserve the balance of my time.